Companies sponsors |
Kite, a Gilead company (axicabtagene ciloleucel) |
|
Association of Cancer Physicians |
|
British Committee for Standards in Haematology |
|
British Geriatrics Society |
|
British Institute of Radiology |
|
British Psychosocial Oncology Society |
|
British Society for Haematology |
|
British Society of Interventional Radiology |
|
Cancer Research UK |
|
Health Lumen |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal College of Radiologists |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
Society and College of Radiographers |
|
UK Clinical Pharmacy Association |
|
UK Cutaneous Lymphoma Group |
|
UK Oncology Nursing Society |
Others |
Department of Health and Social Care |
|
NHS England |
|
NHS Lewisham CCG |
|
NHS North East London CCG |
|
Welsh Government |
Patient carer groups |
African Caribbean Leukaemia Trust |
|
Anthony Nolan |
|
Black Health Agency for Equality |
|
Blood Cancer UK |
|
Cancer Black Care |
|
Cancer Equality |
|
Cancer52 |
|
DKMS |
|
Helen Rollason Cancer Charity |
|
Independent Cancer Patients Voice |
|
Leukaemia Cancer Society |
|
Leukaemia Care |
|
Lymphoma Action |
|
Macmillan Cancer Support |
|
Maggie’s Centres |
|
Marie Curie |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
|
Tenovus Cancer Care |
|
WMUK |
Assessment group |
Cochrane Haematological Malignancies Group |
|
Cochrane UK |
|
Genomics England |
|
Institute of Cancer Research |
|
Leukaemia Busters |
|
Leukaemia UK |
|
Lymphoma Research Trust |
|
MRC Clinical Trials Unit |
|
National Cancer Research Network |
|
National Institute for Health Research |
|
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
Accord Healthcare (bendamustine, carboplatin, cisplatin, cytarabine, epirubicin, etoposide, gemcitabine, oxaliplatin) |
|
Baxter Healthcare (cyclophosphamide, ifosfamide) |
|
Bristol-Myers Squibb Pharmaceuticals (lenalidomide) |
|
Dr Reddy’s Laboratories (bendamustine) |
|
Hospira UK (carboplatin, cisplatin, cytarabine, gemcitabine, oxaliplatin) |
|
Incyte (tafasitamab) |
|
Jazz Pharmaceuticals UK (cytarabine) |
|
Medac UK (epirubicin, etoposide, oxaliplatin |
|
Napp Pharmaceuticals (rituximab) |
|
Neon Healthcare (etoposide) |
|
Pfizer (cytarabine, epirubicin, methylprednisolone, rituximab) |
|
Roche Products (polatuzumab vedotin, rituximab) |
|
Sandoz Ltd (cisplatin, cyclophosphamide, rituximab) |
|
Seacross Pharmaceuticals (bendamustine, oxaliplatin) |
|
Sun Pharmaceutical Company (gemcitabine, oxaliplatin) |
General commentators |
All Wales Therapeutics & Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Department of Health, Social Services and Public Safety for Northern Ireland |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
NHS Alliance |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Health Specialised Services Committee |